Profile
AERI ZTS HLN TAK TEVA VTRS
Company Name Aerie Pharmaceuticals, Inc. Zoetis Inc. Haleon plc Takeda Pharmaceutical Company Limited Teva Pharmaceutical Industries Limited Viatris Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic
Market Cap - $79.26B $43.23B $42.13B $18.71B $15.67B
Employees 0.38K 14.10K 25.41K 49.28K 37.00K 32.00K
CEO Dr. Vicente Anido Ms. Kristin C. Peck Mr. Brian James McNamara Mr. Christophe Weber Mr. Richard D. Francis Mr. Scott Andrew Smith Ph.D.
Ratings
AERI ZTS HLN TAK TEVA VTRS
Quant Rating Score 3 3 3 3 1 3
Quant Rating Neutral Neutral Neutral Neutral Strong Sell Neutral
Trading
AERI ZTS HLN TAK TEVA VTRS
Last Close $15.25 $175.67 $9.48 $13.29 $17.03 $13.13
High 52 $15.25 $199.94 $10.69 $15.08 $18.96 $13.53
Low 52 $15.25 $145.54 $8.01 $12.6 $10.44 $10.05
Price vs. 52 Week High 0 % -12.14 % -11.32 % -11.87 % -10.18 % -2.96 %
Price vs. 52 Week Low 0 % 20.7 % 18.35 % 5.48 % 63.12 % 30.65 %
Total Return
AERI ZTS HLN TAK TEVA VTRS
1 Month Return 0 % -7.27 % -5.01 % -6.08 % -6.33 % 13.48 %
3 Month Return 0 % -3.95 % -3.95 % -11.04 % -6.07 % 12.03 %
6 Month Return 0 % 1.67 % 11.27 % 0.68 % 2.65 % 19.8 %
9 Month Return 0 % -6.75 % 13.81 % -9.84 % 31 % -0.98 %
YTD Return 0 % -10.99 % 15.19 % -6.87 % 63.12 % 21.24 %
1 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
AERI ZTS HLN TAK TEVA VTRS
Dividend Yield Percentage (TTM) - 0.98 % 2.08 % 4.77 % - 3.66 %
Dividend Paid and Capex Coverage Ration (TTM) -30.13 % 2.1 % - 1.29 % 5.06 % 2.39 %
Dividend Per Share (TTM) - 1.73 % 0.16 % 0.63 % - 0.48 %
Payout Ratio (TTM) - 31.44 % - 101.62 % - -65.15 %
Growth
AERI ZTS HLN TAK TEVA VTRS
Asset Growth 7.3 % -4.28 % -2.18 % 8.25 % -1.2 % -4.67 %
Gross Profit Growth 189.4 % 3.7 % 5.85 % -16.6 % 9.64 % -0.9 %
Revenue Growth 133.51 % 5.74 % 4.09 % 5.87 % 6.16 % -5.14 %
Revenue 3 Year 621.88 % 31.98 % 13.9 % 33.13 % -6.92 % -35.32 %
Revenue 5 Year - 53.64 % 32.87 % 149.89 % -23.33 % -41.73 %
Revenue 10 Year - 103.1 % 32.87 % 154.38 % -40.82 % -26.57 %
EBIT Growth 70.9 % 6.27 % 37.26 % 7.34 % -84.52 % -52.55 %
Net Income Growth 59.14 % 10.88 % -1.04 % -54.56 % 76.24 % -97.37 %
Net Income 3 Yeari Growth Per Share 71.08 % 47.55 % -8.67 % -61.74 % 86.29 % 104.09 %
Net Income 5 Yeari Growth Per Share 52.51 % 71.94 % 59.66 % 62.27 % 76.28 % -93.3 %
Net Income 10 Yeari Growth Per Share -97.3 % 404.24 % 59.66 % 36.33 % -133.42 % -97.12 %
Operating Income Growth 70.9 % 6.27 % 37.26 % 7.34 % -84.52 % -52.55 %
Operating Cash Flow Growth (CFG) -53.28 % 23.06 % -16.48 % -34.47 % -13.96 % -5.18 %
Operating 3 Year CFG 41.57 % 14.12 % 22.08 % -36.76 % 10.09 % 13.84 %
Operating 5 Year CFG 21.91 % 37.69 % 118.54 % 139.61 % -48.98 % -48.37 %
Operating 10 Year CFG -182.62 % 274.61 % 118.54 % 335.67 % -67.94 % -16.8 %
EPS Growth 59.65 % 12.64 % - -54.92 % 76.42 % -97.08 %
EPS Diluted Growth 59.65 % 12.92 % - -54.86 % 76.42 % -97.08 %
Book Value Per Share -171.63 % 15.25 % 1.35 % 13.54 % -7.25 % -1.92 %
Share Holder 3 Year Equity Growth Per Share -106.84 % 36.7 % -36.6 % 40.38 % -26.74 % -55.34 %
Share Holder 5 Year Equity Growth Per Share -110.35 % 139.55 % -39.41 % 73.27 % -53.44 % -27.35 %
Share Holder 10 Year Equity Growth Per Share -150.88 % 476.36 % -39.41 % 197.1 % -74.76 % 128.81 %
Dividend Per Share Growth - 15.15 % -85.58 % 1.95 % - -0.06 %
Dividend 3 Year Growth Per Share - 87.76 % -83.69 % 1.19 % - -
Dividend 5 Year Growth Per Share - 198.29 % -66.42 % 146.94 % -100 % -
Dividend 10 Year Growth Per Share - 665.58 % -66.42 % 103.93 % -100 % -
Debt Growth 21.06 % -15.91 % -9.43 % 24.67 % -6.53 % -5.93 %
Free Cash Flow Growth -51.12 % 22.25 % -20.06 % -53.54 % -19.19 % -7.35 %
Updated On 31 Dec 2021 31 Dec 2023 31 Dec 2023 31 Mar 2024 31 Dec 2023 31 Dec 2023
Profitability
AERI ZTS HLN TAK TEVA VTRS
Gross Profit Margin TTM 86.17 % 68.87 % 59.91 % 62.47 % 49.87 % 40.26 %
Return on Assets TTM -17.34 % 16.93 % 3.26 % 1.99 % -2.38 % -1.97 %
Return on Equity TTM -2255.01 % 47.99 % 6.54 % 4.04 % -14.58 % -4.43 %
Return on Capital Employed TTM -14.79 % 26.64 % 7.25 % 5.27 % 7.66 % -0.71 %
Net Income Per EBT TTM 100.8 % 79.65 % 65.38 % 109.03 % 175.89 % 92.81 %
EBT Per Ebit TTM 163.79 % 90.51 % 82.66 % 41.38 % -26.34 % 359.67 %
EBIT Per Revenue TTM -23.34 % 36.83 % 17.88 % 14.14 % 12.76 % -1.76 %
Cash Flow To Debt Ratio TTM -38.04 % 44.8 % - 17.01 % 13 % 13.05 %
Receivables Turnover TTM 1.22 6.49 5.27 6.3 4.85 3.81
Payables Turnover TTM 3.24 7.05 1.25 4.13 3.55 7.23
Inventory Turnover TTM 0.66 1.18 3.09 1.41 2.13 2.2
Fixed Asset Turnover TTM 261.84 % 259.93 % 604.62 % 240.84 % 278.05 % 561.67 %
Asset Turnover TTM 45 % 63.75 % 33.71 % 31.2 % 40.19 % 33.6 %
Operating Cash Flow Per Share TTM -2.14 6.5 - 545.34 2.18 1.93
Free Cash Flow Per Share TTM -2.21 5.1 - 309.43 1.75 1.6
Cash Per Share TTM 301.71 % 378.45 % 5.72 % 57513.46 % 292.94 % 157.41 %
Operating Cash Flow Sales Ratio TTM -51.08 % 32.18 % - 18.9 % 14.71 % 15.29 %
Free Cash Flow Operating Cash Flow Ratio TTM 103.32 % 78.37 % - 56.74 % 80.23 % 83.19 %
Cash Flow Coverage Ratios TTM -38.04 % 44.8 % - 17.01 % 13 % 13.05 %
Price To Free Cash Flows Ratio TTM - 34.34 - 13.34 9.45 8.19
Price To Operating Cash Flows Ratio TTM -7.13 27.02 - 3.76 7.82 6.81
Price Cash Flow Ratio TTM -7.13 27.02 - 3.76 7.82 6.81
Income Statement (TTM)
AERI ZTS HLN TAK TEVA VTRS
Revenue $0.19B $8.54B $11.3B $4263.76B $15.85B $15.43B
Gross Profit $0.17B $5.83B $6.96B $2321.31B $7.65B $6.44B
Gross Profit Ratio 86.17% 68.28% 61.6% 54.44% 48.25% 41.74%
EBITDA $-0.01B $3.69B $2.35B $900.33B $4.33B $3.52B
Net Income $-0.07B $2.34B $1.05B $144.07B $-0.56B $0.05B
EPS Diluted -1.61 5.07 0.11 91.16 -0.5 0.05
Balance Sheet (MRQ)
AERI ZTS HLN TAK TEVA VTRS
Long Term Debt $0.26B $6.75B $8.95B $5029.93B $18.48B $16.35B
Total Liabilities $0.45B $9.3B $17.33B $7834.79B $35.35B $27.22B
Total Equity $-0.02B $4.99B $16.73B $7274.01B $8.13B $20.47B
Total Investments $0.1B $0.02B $0.07B $683.22B $0.01B $1.33B
Total Debt $0.26B $6.76B $9.46B $5463.39B $20.15B $18.37B
Total Assets $0.43B $14.29B $34.06B $15108.79B $43.48B $47.69B
Cash Flow Statement (TTM)
AERI ZTS HLN TAK TEVA VTRS
Net Income $-0.07B $2.34B $1.05B $144.07B $-0.62B $0.05B
Inventory $-0.01B $-0.36B $-0.13B $-115.74B $0B $-0.61B
Dividends Paid $0B $-0.69B $-0.39B $-287.19B $0B $-0.58B
Operating Cash Flow $-0.1B $2.35B $1.72B $640.32B $1.37B $2.8B
Capital Expenditure $-0B $-0.73B $-0.34B $-480.73B $-0.53B $-0.47B
Related Stocks
Ticker Name Price
ACB Aurora Cannabis Inc. 4.3413
ACOR Acorda Therapeutics, Inc. 0.661
ACRX AcelRx Pharmaceuticals, Inc. 0.86
ADMP Adamis Pharmaceuticals Corporation 0.775
ADMS Adamas Pharmaceuticals, Inc. 8.22
AGRX Agile Therapeutics, Inc. 1.51
AKAN Akanda Corp. 1.335
ALIM Alimera Sciences, Inc. 5.54
ALVO Alvotech 12.325
ALVOW Alvotech 3.4
AMPH Amphastar Pharmaceuticals, Inc. 44.105
AMRX Amneal Pharmaceuticals, Inc. 8.385
AMYT Amryt Pharma plc 14.7
ANIP ANI Pharmaceuticals, Inc. 55.54
AQST Aquestive Therapeutics, Inc. 4.56
ASRT Assertio Holdings, Inc. 0.9363
ATNX Athenex, Inc. 0.2031
AVDL Avadel Pharmaceuticals plc 11.18
AYTU Aytu BioPharma, Inc. 1.495
BDSI BioDelivery Sciences International, Inc. 5.59
ETFs With Exposure to AERI
Ticker ETF Name Weight Percentage Price
IWM iShares Russell 2000 ETF 0.03 234.44
ITOT iShares Core S&P Total U.S. Stock Market ETF 0 130.67
IWN iShares Russell 2000 Value ETF 0.01 175.56
IWV iShares Russell 3000 ETF 0 339.625
IWO iShares Russell 2000 Growth ETF 0.05 304.2
VHT Vanguard Health Care Index Fund 0 263.98
BIB ProShares Ultra Nasdaq Biotechnology 0.03 54.3759
HDG ProShares Hedge Replication ETF 0 50.1023
UWM ProShares Ultra Russell2000 0.01 47.6
IWC iShares Micro-Cap ETF 0.17 132.56
FHLC Fidelity MSCI Health Care Index ETF 0.01 68.11
URTY ProShares UltraPro Russell2000 0.01 60.1058
BTEC Principal Healthcare Innovators ETF 0.21 39.49
GSSC Goldman Sachs ActiveBeta U.S. Small Cap Equity ETF 0.14 73.76
IHE iShares U.S. Pharmaceuticals ETF 0.3 67.68
AGNG Global X Aging Population ETF 0.6 30.83
PBSM Invesco PureBeta MSCI USA Small Cap ETF 0.02 31.9152
PSC Principal U.S. Small-Cap Multi-Factor ETF 0.06 54.79
VTWG Vanguard Russell 2000 Growth Index Fund 0.02 221.13
VSTCX Vanguard Strategic Small-Cap Equity Fund Investor Shares 0.05 44.81
SPGM SPDR Portfolio MSCI Global Stock Market ETF 0.01 64.64
MARB First Trust Vivaldi Merger Arbitrage ETF 1.46 19.64
IEIH iShares Evolved U.S. Innovative Healthcare ETF 0.03 34.1348
RYLD Global X Russell 2000 Covered Call ETF 0.03 16.5121
AVUS Avantis U.S. Equity ETF 0 99.71
IBBQ Invesco Nasdaq Biotechnology ETF 0.07 22.1868
JFWD Jacob Forward ETF 2.66 11.8954
BTEC.L iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) 0.07 6.43
WSML.L iShares MSCI World Small Cap UCITS ETF 0.01 7.829
AGED.L iShares Ageing Population UCITS ETF 0.09 7.8525
QQQS Invesco NASDAQ Future Gen 200 ETF 0.53 27.15
IUSN.DE iShares MSCI World Small Cap UCITS ETF 0.01 7.456
SXRG.DE iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced UCITS ETF USD (Acc) 0.03 537.1
VEXPX Vanguard Explorer Fd 0 126.81
WLDS.L iShares MSCI World Small Cap UCITS ETF 0.01 6.212
VHCIX Vanguard HealthCare Index Fund Admiral Shs 0 131.62
JKK iShares Morningstar Small-Cap Growth ETF 0.02 307.42
JKJ iShares Morningstar Small-Cap ETF 0.01 231.193
LNGR Global X Aging Population ETF 0.6 27.75
JKL iShares Morningstar Small-Cap Value ETF 0.01 172.726
Unlock